Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemia
Robert Roskoski
Topics & Concepts
NilotinibPonatinibChronic myelogenous leukemiaDasatinibPhiladelphia chromosomeBosutinibImatinibCancer researchChromosomal translocationABLFusion proteinMedicineLeukemiaPharmacologyChemistryBiologyImmunologyInternal medicineTyrosine kinaseGeneticsMyeloid leukemiaReceptorGeneRecombinant DNAChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchPI3K/AKT/mTOR signaling in cancer